Alzheimer’s disease (AD) is related to higher mortality but it is not entirely evident which causes of death explain this. The objective of this study was to assess the causes of death in a nationwide cohort of clinically verified AD cases and compare the causes to a matched comparison cohort without AD.
Methods
Cohort of all community-dwellers with clinically verified AD residing in Finland on 31 December 2005 (n = 27,948) and a matched comparison cohort without AD (n = 27,948). Mortality (2006–2012, n = 30,641, 54.8%) and causes of death were obtained from register. Cause of death was ascertained with clinical examination (87.3% of deaths), forensic (8.0%) or medical autopsy (4.7%).
Results
In AD cohort, the most common causes were diseases of the nervous system (49.9%), circulatory system (31.7%) and neoplasms (7.7%), while diseases of circulatory system (53.5%), neoplasms (19.1%) and mental and behavioral disorders (7.3%) contributed for majority of deaths in the comparison cohort. There were no sex-wise differences. People with AD were over 20 times more likely to die due to diseases of the nervous system (OR, 95% CI 22.06, 19.87–24.25) than the comparison cohort, while other causes, e.g., diseases of the circulatory system (0.40, 0.38–0.42), neoplasms (0.35, 0.33–0.38), mental and behavioral disorders (0.27, 0.24–0.30) and external causes of morbidity and mortality (0.72, 0.62–0.81) were less common in the AD cohort.
Conclusions
Although half of the people with AD died due to diseases of the nervous system, cancers and especially cardio/cerebrovascular diseases were still important contributors to the overall mortality among them. This should be acknowledged when planning their terminal care.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AD
Alzheimer’s disease
MEDALZ-2005
The Medication and Alzheimer’s Disease 2005 study
SII
Social Insurance Institution of Finland
Background
Persons with Alzheimer’s disease, the most common form of dementia, have higher mortality in comparison to matched population without dementia [1‐4]. The increase in mortality has been implied to be larger in men [5], and pneumonia and cardiovascular diseases are suggested as the main contributors for the increased mortality [6‐13]. Most [7‐11] of these studies have been autopsy series, and have thus included a selected sample of persons with Alzheimer’s disease (AD). As only few population-based cohort studies on the causes of death have been conducted [6, 12, 13], it is not entirely evident which causes of death explain the difference in mortality. A recent study, based on the Swedish dementia register showed that circulatory causes were the most common underlying cause of death in persons with dementia (37% of deaths), followed closely by dementia (30% of deaths) [13].
We investigated the causes of death in a nationwide sample of community-dwelling persons with clinically verified AD diagnosis and compared them to a matched comparison cohort without AD. We also assessed whether the causes of death were different among those who underwent medical or forensic autopsy. Since registers, including the causes of death register are sometimes used to ascertain dementia/AD status in epidemiological studies, we assessed which proportion of the clinically verified AD cases would be identified with the causes of death register. Previous studies from England and Wales [14] and Sweden [13] have shown that although recording dementia on death certificate has improved over time [14], it is still an underestimate.
Anzeige
Methods
Study population
The Medication and Alzheimer’s Disease 2005 (MEDALZ-2005) study cohort includes all community-dwelling persons with a verified diagnosis of Alzheimer’s disease residing in Finland on 31 December 2005 (n = 28,093) and a single age-, sex- and region of residence- matched comparison person for each individual with AD (n of comparison cohort = 28,093, N = 56,186) [15]. The age range of the cohort was 42–101 years (mean 79.9 (SD 6.8) years) and 38,086 (67.8%) of the sample were women. Each resident of Finland is assigned a personal identification number which was used to obtain data on mortality and causes of death between Jan 1, 2006 and Dec 31, 2012 from the Causes of death register, maintained by the Statistics Finland. Data on comorbidities were obtained from national registers as described in Supplementary Table 1.
Diagnosis of Alzheimer’s disease
Persons with AD were identified from the Finnish Special Reimbursement Register maintained by the Social Insurance Institution of Finland (SII) as described in detail previously [15]. Briefly, the specific criterion for a verified AD diagnosis is 1) symptoms consistent with mild or moderate AD, 2) a decrease in social capacity over a period of at least 3 months, 3) a computer tomography/magnetic resonance imaging scan, 4) exclusion of other reasons for symptoms (for example vascular or frontotemporal dementia, hyperparathyreoidism, hypothyreoidism or severe depletion of vitamin B12), and 5) confirmation of the diagnosis by a registered neurologist or geriatrician. The AD diagnosis was based on the NINCDS-ADRDA and DSM-IV criteria for Alzheimer’s disease [16, 17]. Persons with some findings related to other dementive disorder (e.g. a few lacunar infarcts) were included if the symptoms were mainly caused by AD. The comparison persons were identified from the register that contains all residents of Finland who are entitled to benefits by the SII, i.e. all citizens and residents living in Finland for at least 2 years.
Causes of death
The Causes of death register is compiled from death certificate data. It covers persons who have died in Finland or abroad during the calendar year and who at the time of death were domiciled in Finland. Underlying cause of death, direct cause, intervening causes and up to four contributing causes are registered.
Death certificates are issued by physicians and if an autopsy is required, the death certificate is issued by a medicolegal officer after completion of the autopsy. Death certificates are submitted to the regional unit of the National Institute for Health and Welfare of the region where the deceased resided. Provincial medical officer confirms the certificates before they are sent on to Statistics Finland for registration. Forensic autopsies were performed for 21%, and medical autopsy for 6.7% of all deaths in Finland 2011 [18].
Anzeige
In this study, the underlying and direct causes of death were classified to main classes of according to ICD-10 classification system (Table 1). Underlying cause is the disease that initiated the series of illnesses leading directly to death, or the circumstances connected with an accident/act of violence which caused the injury/poisoning leading to death. Direct cause refers to the disease, failure or injury whose symptoms caused the death.
Table 1
Underlying and Direct Causes of Death in the Comparison (No AD) and AD Cohorts of the MEDALZ-2005 Study
Category
ICD-10 code
No AD, n = 10,171
AD, n = 20,470
OR (95%CI
Diseases of the circulatory system
I*
5441 (53.5)
6484 (31.7)
0.40 (0.38, 0.42)
Diseases of the nervous system
G*
440 (4.3)
10,218 (50.0)
22.06 (19.87, 24.25)
Neoplasms
C*, D00-D48
1942 (19.1)
1573 (7.7)
0.35 (0.33, 0.38)
Mental and behavioral disorders
F*
741 (7.3)
425 (2.1)
0.27 (0.24, 0.30)
Diseases of the respiratory system
J*
512 (5.0)
380 (1.9)
0.36 (0.31, 0.40)
External causes of morbidity and mortality
V*, W*, X*, Y*
356 (3.5)
518 (2.5)
0.72 (0.62, 0.81)
Diseases of the digestive system
K*
308 (3.0)
423 (2.1)
0.68 (0.58, 0.78)
Certain infectious and parasitic diseases
A*, B*
89 (0.9)
96 (0.5)
0.53 (0.40, 0.71)
Diseases of the genitourinary system
N*
132 (1.3)
156 (0.8)
0.58 (0.46, 0.74)
Endocrine, nutritional and metabolic diseases
E*
115 (1.1)
116 (0.6)
0.50 (0.38, 0.65)
Diseases of the musculoskeletal system and connective tissue
M*
49 (0.5)
21 (0.1)
0.21 (0.13, 0.35)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D50-D89
10 (0.1)
11 (0.1)
0.55 (0.23, 1.29)
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
R*
10 (0.1)
17 (0.1)
0.84 (0.39, 1.85)
Congenital malformations, deformations and chromosomal abnormalities
Q*
8 (0.1)
13 (0.1)
0.81 (0.33, 1.95)
Diseases of the skin and subcutaneous tissue
L*
9 (0.1)
4 (< 0.1)
0.22 (0.07, 0.72)
Diseases of the eye, adnexa, ear and mastoid process
H*
2 < (0.1)
0 (0.0)
N.A
Table 2
Underlying and Direct Causes of Death among People with AD Stratified by Age at AD Diagnosis
Category
ICD-10 code
< 65 years n = 409
≥65 years n = 20,061
OR (95%CI
Diseases of the circulatory system
I*
48 (11.7)
6436 (32.1)
3.55 (2.47–4.62)
Diseases of the nervous system
G*
293 (71.6)
9925 (49.5)
0.38 (0.30–0.47)
Neoplasms
C*, D00-D48
18 (4.4)
1555 (7.8)
1.82 (0.96–2.69)
Mental and behavioral disorders
F*
12 (2.9)
413 (2.1)
0.69 (0.29–1.10)
Diseases of the respiratory system
J*
5 (1.2)
375 (1.9)
1.54 (0.17–2.90)
External causes of morbidity and mortality
V*, W*, X*, Y*
10 (2.4)
508 (2.5)
1.03 (0.38–1.69)
Diseases of the digestive system
K*
6 (1.5)
417 (2.1)
1.42 (0.27–2.58)
Certain infectious and parasitic diseases
A*, B*
0 (0)
96 (0.5)
N. A
Diseases of the genitourinary system
N*
1 (0.2)
155 (0.8)
3.17 (0.01–9.41)
Endocrine, nutritional and metabolic diseases
E*
4 (1.0)
112 (0.6)
0.57 (0.00–1.14)
Diseases of the musculoskeletal system and connective tissue
M*
1 (0.2)
20 (0.1)
0.41 (0.00–1.22)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D50-D89
0 (0)
11 (0.1)
N. A
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
R*
1 (0.2)
16 (0.1)
0.33 (0.01–0.98)
Congenital malformations, deformations and chromosomal abnormalities
Q*
9 (2.2)
4 (< 0.1)
0.01 (0.00–0.02)
Diseases of the skin and subcutaneous tissue
L*
0 (0)
4 (< 0.01)
N. A
Statistical analyses
Altogether 145 persons in the comparison cohort had been temporarily entitled to reimbursed AD medication before 2006 and they, together with their matched pairs, were excluded from the study. Of the remaining 55,896 participants, 3415 converted to AD during the follow-up and deaths were ascertained to AD cohort (according to AD status at the time of death). These people had no matched comparison person without AD, and we also performed sensitivity analyses excluding these 3415 pairs but this did not have a significant effect on the results (data not shown). Differences on the causes of death were assessed with risk ratios, derived from logistic regression. Possible sex differences were investigated by including a sex*AD interaction term in the model. Age-stratified analyses, with 65 years as a cutoff were performed in people with AD to assess possible differences between those with early and late-onset AD. Associations between comorbidities and mortality were investigated with logistics regression.
We assessed how often Alzheimer’s Disease (ICD-10 code G30) or dementia (F00, F01, F02, F03, G30, F051, F107, F117, F147, F167, F187 and F197) were listed as underlying, direct or intervening cause of death or any cause of death and whether AD was more often mentioned in the death certificate for those with longer duration of disease using logistic regression. Duration of disease was defined as time since clinically verified AD diagnosis at the time of death. Likelihood ratio tests demonstrated nonlinear association between AD duration and likelihood of having AD or dementia listed as cause of death. Therefore, we do not present OR per one-year increase in disease duration.
Results
Sample characteristics
Altogether 30,641 cohort members (20,470 with AD, 10,171 without AD) died during the follow-up. The median length of the follow-up was 6.3 years (range 1 day to 7 years). Consistent with our previous results on survival from the same cohort with shorter follow-up (4.8 years) [1], men were approximately 50% more likely to die than women and the sex difference was more pronounced in the AD cohort (HR, 95% CI 1.59, 1.55–1.64) than in the non-AD group (HR 1.47, 1.41–1.53). People with AD were 1.8 years younger when they died (average age at death 84.4 and 86.2 years for AD and non-AD groups, respectively). In both AD and comparison cohorts, all baseline comorbidities (cardiovascular disease, diabetes, stroke, asthma/chronic obstructive pulmonary disease, hip fracture, rheumatoid arthritis and cancer) were associated with mortality (Supplementary Table 2).
Information on any cause of death was not available for 14 participants in the AD cohort and 8 in the comparison cohort (0.07 and 0.07%, respectively). These persons were excluded from the analysis. Underlying or direct cause of death was listed for 30,619 individuals (97.3%), ascertained with clinical examination for 89.7% of the AD cohort (n = 18,357) and 82.1% (n = 8352) of the comparison cohort. Of the AD cohort, 6.0% (n = 1234) underwent forensic autopsy and 4.2% (n = 851) medical autopsy while 11.9% (n = 1210) and 5.8% (n = 594) of the comparison cohort underwent forensic and medical autopsy, respectively.
Causes of death
In the AD cohort, the most common main/direct causes of death were diseases of the nervous system (49.9%), circulatory system (31.7%) and neoplasms (7.7%), accounting for nearly 90% of deaths in this cohort (Table 1). In the comparison cohort, the most common causes of death were diseases of circulatory system (53.5%), neoplasms (19.1%), mental and behavioral disorders (7.3%) and diseases of the nervous system (4.3%), accounting for 84.2% of deaths. The frequency of other causes was < 5% in both groups and the absolute differences between groups were small for these less common causes. People with AD were less likely to die due to diseases of the circulatory, respiratory, digestive, genitourinary or musculoskeletal system, neoplasms, external causes of morbidity and mortality or mental and behavioral disorders and as expected, over 22 times more likely to die due to diseases of the nervous system.
More detailed diagnoses are listed in Supplementary Table 3. Ischemic heart disease and stroke were the most common circulatory diseases in both cohorts and lung cancer was the most common cancer diagnosis. Of diseases of the nervous system, Alzheimer’s disease was the most common followed by Parkinson’s disease in both cohorts. Mental and behavioral disorder diagnoses were mainly dementia diagnoses in both cohorts.
In the age at diagnosis-stratified analysis of AD cases, diseases of circulatory system were more commonly recorded as the main or direct cause of death among those with later onset (Table 2). Diseases of the nervous system were more common among those with earlier onset. Congenital malformations, deformations and chromosomal abnormalities, together with abnormal laboratory findings were also more commonly listed as the main cause of death for those with younger age at AD diagnosis, but the number of these cases was fairly low.
Anzeige
In the AD cohort, the distribution of most causes was similar in both sexes (Table 3). Negative association between AD and deaths due to diseases of the circulatory system and mental and behavioral disorders and the positive association between AD and diseases of nervous system were stronger in men than in women.
Table 3
Underlying and Direct Causes of Death among Men and Women
Category
Men N = 10,934
Women N = 19,707
P for sex difference
No AD n = 3654
AD n = 7280
No AD n = 6517
AD n = 13,190
Diseases of the circulatory system
1842 (50.4)
2202 (30.2)
3599 (55.2)
4282 (32.5)
0.078
Diseases of the nervous system
123 (3.4)
3541 (48.6)
317 (4.9)
6677 (50.6)
0.006
Neoplasms
830 (22.7)
667 (9.2)
1112 (17.1)
906 (6.9)
0.56
Mental and behavioral disorders
191 (5.2)
152 (2.1)
550 (8.4)
273 (2.1)
< 0.001
Diseases of the respiratory system
280 (7.7)
228 (3.1)
232 (3.6)
152 (1.2)
0.13
External causes of morbidity and mortality
141 (3.9)
197 (2.7)
215 (3.3)
321 (2.4)
0.71
Diseases of the digestive system
101 (2.8)
136 (1.9)
207 (3.2)
287 (2.2)
0.94
Certain infectious and parasitic diseases
30 (0.8)
37 (0.5)
59 (0.9)
59 (0.4)
0.46
Diseases of the genitourinary system
46 (1.3)
45 (0.6)
86 (1.3)
111 (0.8)
0.31
Endocrine, nutritional and metabolic diseases
41 (1.1)
44 (0.6)
74 (1.1)
72 (0.5)
0.67
Diseases of the musculoskeletal system and connective tissue
12 (0.3)
4 (0.1)
37 (0.6)
17 (0.1)
0.64
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
3 (0.1)
5 (0.1)
7 (0.1)
6 (< 0.1)
0.46
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
6 (0.2)
7 (0.1)
4 (0.1)
10 (0.1)
0.36
Congenital malformations, deformations and chromosomal abnormalities
1 (< 0.1)
5 (0.1)
7 (0.1)
8 (0.1)
0.22
Diseases of the skin and subcutaneous tissue
4 (0.1)
2 (< 0.1)
5 (0.1)
2 (< 0.1)
0.84
Diseases of the eye, adnexa, ear and mastoid process
1 (< 0.1)
0 (0.0)
1 (< 0.1)
0 (0.0)
N.A
Causes of death in autopsied participants
Causes of death for autopsied participants are listed in Table 4. As with all deaths (Table 1), deaths due to circulatory causes and neoplasms were less common and deaths due to diseases of the nervous system more common in the AD cohort in the autopsied subsample. Diseases of the circulatory system were the most common autopsy-confirmed reason for death (> 50%) in both cohorts, regardless of autopsy type (medical or forensic). In the subgroup autopsied for medical reasons, other common autopsy-confirmed causes of death were neoplasms and diseases of the digestive system (≥10.0% in both cohorts) and diseases of the nervous system (17.7% in the AD cohort). Approximately one fourth of the deaths in the AD cohort and one fifth of the deaths in the comparison cohort confirmed with forensic autopsy were due to external causes.
Table 4
Underlying and Direct Causes of Death in Autopsied Participants of the MEDALZ-2005 Study
Congenital malformations, deformations and chromosomal abnormalities
2 (0.1)
1 (< 0.1)
0.43 (0.04, 4.77)
1 (0.2)
0 (0.0)
NA
1 (0.1)
1 (0.1)
0.98 (0.06, 15.69)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0 (0.0)
1 (< 0.1)
NA
0 (0.0)
0 (0.0)
NA
0 (0.0)
1 (0.1)
N.A
Alzheimer’s disease as a cause of death
Alzheimer’s disease was included as an underlying, direct or intervening cause of death for 48.3% (n = 9880) of people in the AD cohort and 2.8% (n = 282) people in the comparison cohort. Altogether 71.0% (n = 14,537) of the AD cohort and 4.1% (n = 413) of the matched comparison cohort had AD listed as any cause of death (including also contributory causes). Fifty-one percent (n = 10,407) of the AD group and 10.2% (n = 1042) of the comparison cohort had any form of dementia listed as an underlying, direct or intervening cause of death and 75.3% (n = 15,404) of the death certificates of AD cases and 15.6% (n = 1589) of the comparison group had any mention of dementia. Of these 1589 persons, 42.4% had unspecified dementia, 29.0% had vascular dementia and 26.0% had Alzheimer’s disease. The remaining 2.6% had other forms of dementia. The likelihood for having AD as the underlying, direct or intervening cause of death increased nonlinearly with the duration of disease until (Fig. 1a, Supplementary Table 4). Similar association was observed between any mention of AD in the death certificate and years since AD diagnosis (Fig. 1b, Supplementary Table 4).
Fig. 1
Odds for including AD as a an underlying direct or intervening cause of death or b any cause of death according to duration of AD
×
When the analyses were restricted to those deaths that were not due to dementia (i.e. did not have dementia as underlying, direct or underlying cause of death), diseases of the circulatory system and neoplasms remained as the most common underlying/direct cause of death. Diseases of the circulatory system accounted for 62.1% deaths in the whole cohort and 59.6 and 64.4% of deaths in the non-AD and AD cohorts, respectively (Table 5). In comparison to results presented in Table 1, the proportion of deaths due to neoplasms increased in the AD cohort and the proportion of deaths due to diseases of the nervous system decreased significantly.
Table 5
Underlying and Direct Causes of Death in the Comparison (No AD) and AD Cohorts of the MEDALZ-2005 Study after Excluding Deaths with Dementia as the Underlying, Direct or Intermediate Cause of Death
Category
ICD-10 code
No AD, n = 9129
AD, n = 10,063
OR (95%CI)
Diseases of the circulatory system
I*
5438 (59.6)
6481 (64.4)
1.23 (1.16, 1.30)
Diseases of the nervous system
G*
124 (1.4)
234 (2.3)
1.73 (1.39, 2.16)
Neoplasms
C*, D00-D48
1942 (21.3)
1573 (15.6)
0.69 (0.64, 0.74)
Mental and behavioral disorders
F*
18 (0.2)
5 (< 0.1)
0.25 (0.09, 0.68)
Diseases of the respiratory system
J*
512 (5.6)
380 (3.8)
0.66 (0.58, 0.74)
External causes of morbidity and mortality
V*, W*, X*, Y*
356 (3.9)
518 (5.1)
1.34 (1.17, 1.54)
Diseases of the digestive system
K*
308 (3.4)
423 (4.2)
1.26 (1.08, 1.46)
Certain infectious and parasitic diseases
A*, B*
89 (1.0)
96 (1.0)
0.98 (0.73, 1.31)
Diseases of the genitourinary system
N*
132 (1.4)
156 (1.6)
1.07 (0.85, 1.36)
Endocrine, nutritional and metabolic diseases
E*
115 (1.3)
116 (1.2)
0.91 (0.71, 1.19)
Diseases of the musculoskeletal system and connective tissue
M*
49 (0.5)
21 (0.2)
0.39 (0.23, 0.64)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D50-D89
10 (0.1)
11 (0.1)
1.00 (0.42, 2.35)
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
R*
10 (0.1)
17 (0.2)
1.54 (0.71, 3.37)
Congenital malformations, deformations and chromosomal abnormalities
Q*
8 (0.1)
13 (0.1)
1.48 (0.61, 3.56)
Diseases of the skin and subcutaneous tissue
L*
9 (0.1)
4 (< 0.1)
0.40 (0.12, 1.31)
Diseases of the eye, adnexa, ear and mastoid process
H*
< 2 (0.1)
0 (0.0)
N.A
Anzeige
Discussion
Diseases of the nervous system, including AD, were the most common underlying or direct cause of death in our nationwide cohort of community-dwelling persons with AD, accounting for 50% of deaths. This is expected, as AD per se is related to higher mortality [1‐5]. In our study, diseases of the circulatory system and neoplasms were among the leading causes in those with and without AD, but they were more common in the comparison cohort without AD. The differences in causes of death by age at AD diagnosis were not surprising as older persons have more cardiovascular comorbidities.
AD was listed as a cause of death for 4.1% of the comparison group. As our AD diagnoses were obtained from the Special reimbursement register (i.e. patients with AD who were eligible for reimbursed AD medication), these comparison persons may have been persons with AD who were not deemed to benefit from anti-dementia medication, may have had contraindications for these medicines or had not received the decision for reimbursed medication before their death.
Since most of the previous studies are autopsy series, our results are not directly comparable with them. Death certificates are meant to reflect the relevant information regarding cause of death, but the degree of precision may vary within and between institutions, as well as over time. In a previous validation study of 58 dementia cases, the agreement between death certificate and autopsy was 53% and especially the contribution of bronchopneumonia was underestimated [11]. Although the proportion of deaths due to respiratory conditions, including bronchopneumonia, was much lower in our study than in the previous ones that have reported estimates for persons with AD [7‐9, 11‐13], the proportion of persons with diseases of circulatory system was very similar to that reported in these studies. In 2005, the Finnish classification of bronchopneumonia deaths was changed so that bronchopneumonia was less often accepted as a main cause of death for those with long-term illness [18]. This change, deriving from ICD-9 to ICD-10 transition, may explain the lower proportion of deaths due to bronchopneumonia in our study (follow-up 2006–2013) because all deaths in the previous studies occurred earlier [7‐9, 11, 12]. However, in one Swedish autopsy study with higher proportion of bronchopneumonia deaths, the causes of death were ascertained according to ICD-10 [8].
The differences between ours and previous results can also partially be due to difficulties in ascertaining the cause of death without autopsy. However, it should be noted that our sample represents people with AD who were community-dwelling in the beginning of the study and thus they may be very different to those people with AD who undergo a medical autopsy. Some of the previous cohort studies have also included cases from a long period of time [6, 8]. This, together with changes in life expectancy and treatment of people with AD and temporal changes in causes of death [18, 19], means that the differences may also reflect true differences in the contributing causes. Further, there may be some variation in the causes of death depending on level of cognitive impairment [20], but this kind of data were not available for our study.
Anzeige
One of the strengths of our study is the availability of matched controls. Due to the carefully maintained national registers of Finland, we were able to obtain a nationwide sample of all clinically verified AD cases at certain time point and obtain accurate data on time of death, as well as the information of death certificates for all deceased individuals. We were also able to assess whether the causes of death were different among those who underwent forensic or medical autopsy.
Our data is not in agreement with the suggestion that additional causes of death might not be considered if the deceased was already diagnosed with AD or other form of dementia as approximately 50% of deaths in the AD cohort were assigned to causes other than AD or dementia. AD was mentioned as a cause of death for 70% of clinically verified AD cases, a proportion comparable to a previous study based on Swedish Dementia register [13]. This has implications for using the causes of death register for AD status ascertainment in epidemiological studies. The lack of mention of dementia/AD in all certificates of the AD group does not necessarily reflect incompetent or incomplete certification, because dementia/AD may not have contributed to death in all cases. In a previous study, dementia was less often disclosed in the death certificate when the duration of disease was less than 5 years [12]. This is in line with our findings on the positive association between AD duration and inclusion of AD in the death certificate.
Conclusions
Although half of the people with AD in our nationwide cohort died of diseases of the nervous system, cancers and especially cardio- and cerebrovascular diseases were still important contributors to the overall mortality among them. This finding was confirmed in the autopsied subsample. Although men with AD had shorter survival in comparison to women, there were no important sex differences in the causes of death. This knowledge about the causes death is valuable for planning the terminal care of patients with AD.
Acknowledgements
Not applicable.
Ethics approval and consent to participate
No ethics committee approval or informed consent were required as only de-identified data was used and the study participants were not contacted.
Consent for publication
Not applicable.
Competing interests
AMT, MK and SH report no competing interests. HT and JT have participated in research projects funded by Janssen-Cilag and Eli Lilly with grants to the institution where they are employed. JT has received personal fees from the Finnish Medicines Agency (Fimea), European Medicines Agency (EMA), Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka; and has received grants from the Stanley Foundation and Sigrid Jusélius Foundation.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
